OPUS-2: Lifitegrast improves symptoms but not signs of dry eye disease

BOSTON β€” Of two co-primary endpoints of the OPUS-2 study, signs and symptoms of dry eye disease, one was met and one was not, according to a speaker here. β€œThe study robustly met the primary endpoint for symptom, with a P value of .0001; however, there was no statistically significant difference for the endpoint sign of corneal staining,” Joseph Tauber, MD, said at the American Society of Cataract and Refractive Surgery annual meeting.

Full Story β†’